Inactive Instrument

All News Vansen Pharma Inc.

Equities

Vansen Pharma Inc. will Change its Ticker to VNSN.E from VNSN	21/14/21	CI
Vansen Pharma Inc. acquired Canadian Health Empire and 6708595 CANADA INC. from Kazem Agharazi for CAD 0.47 million.	17/14/17	CI
Vansen Pharma Inc. Appoints Ali Moghaddam to its Board of Advisors	06/14/06	CI
Vansen Pharma Inc. Announces Management Changes	03/14/03	CI
Vansen Pharma Inc has Changed its Ticker to OKNVD from VNSN	30/13/30	CI
Vansen Pharma Inc. will Change its Ticker to VNSN from OKNV.D	30/13/30	CI
Okana Ventures Inc. has Changed its Name to Vansen Pharma Inc	30/13/30	CI
Okana Ventures Inc. acquired Factive product from Merus Labs International Inc. for $3.4 million.	26/13/26	CI
Okana Ventures Inc. Announces Management Changes	08/13/08	CI
Okana Ventures Inc. acquired right, title and interest to certain Spectracef® and Cefditoren Pivoxil products from Vansen Pharma Inc. for $13.6 million.	08/13/08	CI
Okana Ventures Inc. announced that it has received $1.45 million in funding.	30/13/30	CI
Okana Ventures Inc. Auditor Raises 'Going Concern' Doubt	13/13/13	CI

No results for this search